Study looks at efficacy of hemoglobin thresholds for transfusion

For patients with acute myocardial infarction (MI) and anemia, 30-day risks for death or recurrent MI seem to increase with lower hemoglobin thresholds for transfusion, according to research published online Oct. 1 in the Annals of Internal Medicine.

Gerard T. Portela, Ph.D., from the University of Pittsburgh, and colleagues estimated the efficacy of four individual hemoglobin thresholds (anemia in a secondary analysis of the Myocardial Ischemia and Transfusion (MINT) trial conducted in 144 sites in six countries. Data were included for 3,492 MINT trial participants with acute MI.

The researchers found that the 30-day risk for death or recurrent MI (death/MI) was 14.8, 15.1, 15.9, and 18.3 percent for a

“The imprecision of these estimates, however, prevents explicit recommendations about individual hemoglobin transfusion thresholds,” the authors write.

More information:
Gerard T. Portela et al, Effect of Four Hemoglobin Transfusion Threshold Strategies in Patients With Acute Myocardial Infarction and Anemia, Annals of Internal Medicine (2024). DOI: 10.7326/M24-0571

Evan M. Bloch et al, Relaxing Transfusion Thresholds for Patients With Myocardial Infarction: Findings From the MINT Trial, Annals of Internal Medicine (2024). DOI: 10.7326/M24-0895

2024 HealthDay. All rights reserved.

Citation:
Study looks at efficacy of hemoglobin thresholds for transfusion (2024, October 1)
retrieved 6 October 2024
from https://medicalxpress.com/news/2024-10-efficacy-hemoglobin-thresholds-transfusion.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.





Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Before you post, please prove you are sentient.

What is 9 times 3?

Explore More

Raised blood pressure is the leading risk factor for death in Australia

Raised blood pressure has been the leading risk factor for death in Australia for the past three decades, according to a study published February 21, 2024, in the open-access journal

Read More

Bivalirudin found to be safer and more effective than heparin for treating heart attack patients undergoing percutaneous coronary intervention

Bivalirudin is a safer and more effective anticoagulant than heparin for treating patients with the most serious type of heart attacks who undergo urgent percutaneous coronary intervention (PCI), and can

Read More

Later-onset menopause linked to healthier blood vessels, lower heart disease risk

Women who go through menopause later in life have healthier blood vessels for years to come than those who go through it earlier, according to new University of Colorado Boulder

Read More